Your Article Summary
See Latest ArticlesMaasland L et al. – Data confirm that pts with ischemic attack and stroke in randomized clinical trials are only partially representative of pts in clinical practice. Use of less strict enrollment criteria may enhance "generalizability" and result in more efficient selection of pts for randomized clinical trials.
Methods- Estimate of the eligibility for participation in landmark trials of antiplatelet drugs of an unselected group of pts with stroke or transient ischemic attack from a national stroke survey
- Prospective study of 972 pts transient ischemic attack or ischemic stroke from Netherlands Stroke Survey
- Application of 7 large antiplatelet trials' enrollment criteria
- In total, 886 pts discharged alive and available for secondary prevention
- Mean follow-up: 2.5 yrs
- Annual rate of transient ischemic attack, stroke, or nonfatal myocardial infarction: 6.7%
- Proportion of pts fulfilling trial enrollment criteria: 25%-67%
- Mortality significantly higher in ineligible pts (27%-41%) than in pts fulfilling enrollment criteria (16%-20%)
- Rates of vascular events not higher in trial-eligible pts than in ineligible pts
Related Articles
Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis
European Journal of Neurology, 11/24/09
Relevance Score: 67%%
eNOS gene influences platelet phenotype in acute coronary syndrome patients on dual antiplatelet treatment
Platelets, 11/23/09
Relevance Score: 66%%
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
Relevance Score: 65%%
Types of Thromboembolic Complications in Coil Embolization for Intracerebral Aneurysms and Management
Journal of Korean Neurosurgical Society, 11/04/09
Relevance Score: 65%%
Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial
European Journal of Neurology, 11/25/09
Relevance Score: 64%%
Today in Stroke/Vascular...keeping you current
Receive free subspecialty "5-minute updates" via email
EEG Power Spectrum to Predict Prognosis after Hemicraniectomy for Space-Occupying Middle Cerebral Artery Infarction
Cerebrovascular Diseases, 12/04/09
Is Moderate Atherosclerotic Stenosis in the Middle Cerebral Artery a Cause of or a Coincidental Finding in Ischemic Stroke
Cerebrovascular Diseases, 12/04/09
Cyclooxygenase-2 (COX-2) G-765C is a protective factor for coronary artery disease but not for ischemic stroke: A meta-analysis
Atherosclerosis, 12/04/09